AbbVie (ABBV)

The recent rally could pave the way for "sell the news" volatility, but don't let this scare you out of a long-term position.

Both have very promising futures.

AbbVie has an attractive 2.7% yield, a solid pharmaceutical business, and is clearly focused on its dividend.

There are plenty of reasons to love these companies.

When quality goes on sale, it's time to back up the truck.

It looks like a great buy-and-hold option.

PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield.

There's no need to panic.

They can help stabilize your portfolio in these otherwise volatile times.

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 1.69% on an annualized basis producing an average annual return of 14.83%. Currently, AbbVie has a market capitalization of $454.46 billion.

AbbVie, Enbridge, and Coca-Cola pay high dividends and are the types of stocks that investors can buy and forget about.

Drug pricing matters, but pipelines matter even more.

You need to look beyond the tech sector to find great dividend stocks for the long term.

AbbVie inherited its status as a Dividend King, but it is building a strong foundation to continue the dividend streak.

Five Dividend Kings—Procter & Gamble, Hormel, Stanley Black & Decker, Genuine Parts and Lowe's—trade at discounted valuations, offering attractive yields despite near-term business headwinds.

The stock is down, but it isn't out yet.

Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.

Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underwriters fully exercised, signaling strong institutional demand.

It doesn't get much more dependable and lucrative than the healthcare industry.

This dividend ETF's focus beyond yield continues to pay off for investors.

Look for history to repeat itself with Apple's latest pullback.

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its pe...